{"podcast":{"title":"JHLT: The Podcast","slug":"jhlt-the-podcast-3498579","podcast_index_feed_id":3498579,"rss_url":"https://thejhlt.libsyn.com/rss","website_url":"http://thejhlt.libsyn.com/website","image_url":"https://static.libsyn.com/p/assets/1/7/d/b/17dbae524013e476/JHLT_PodcastLogo.png","author":"Jessica Burke","episode_count":87,"summary":"The Journal of Heart and Lung Transplantation podcast airs each month and features the JHLT Digital Media Editors in round table talks with the Journal's contributors.","last_synced_at":"2026-06-17T14:18:19.340005+00:00","page_url":"https://stenobird.com/podcast/jhlt-the-podcast-3498579"},"episode":{"title":"Episode 76: Evolocumab's Impact on Coronary Physiology and Microstructure in De Novo Heart Transplant Recipients","slug":"episode-76-evolocumab-s-impact-on-coronary-physiology-and-microstructure-in-de-novo-heart-transplant-recipients","published_at":"2026-01-21T05:30:00+00:00","page_url":"https://stenobird.com/podcast/jhlt-the-podcast-3498579/episode-76-evolocumab-s-impact-on-coronary-physiology-and-microstructure-in-de-novo-heart-transplant-recipients","show_page_url":"https://stenobird.com/podcast/jhlt-the-podcast-3498579","url":"https://thejhlt.libsyn.com/episode-76-evolocumabs-impact-on-coronary-physiology-and-microstructure-in-de-novo-heart-transplant-recipients","audio_url":"https://traffic.libsyn.com/secure/thejhlt/JHLT_jan_2026_pt_2.mp3?dest-id=2489450","summary":"JHLT: The Podcast returns with an episode discussing the paper, \" Impact of evolocumab on coronary physiology and microstructure in de-novo heart transplant recipients ,\" from the January issue of JHLT . Featured on this episode is early career guest host Bin Yang, MD , of Massachusetts General Hospital. Mentored by Digital Media Editor Van-Khue Ton, MD, PhD , Dr. Yang shares hosting duties this episode and brings great questions to the discussion. Drs. Yang and Ton are joined by the first author, Salma Karim , and senior author, Hans Eiskjaer , both from Aarhus University Hospital in Denmark. The discussion explores: What imaging and physical markers the researchers used to determine if evolocumab was influencing the development of cardiac allograft vasculopathy (CAV) The potential role of lipid-lowering therapies or statins in treating CAV The relationship between CAV and microvascular resistance (IMR) For the latest studies from JHLT , visit www.jhltonline.org/current , or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt . In case you missed it, earlier this month the JHLT Digital Media Editors recapped their favorite papers from 2025. Take a listen! Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org .","meta_description":"JHLT: The Podcast returns with an episode discussing the paper, \" Impact of evolocumab on coronary physiology and microstructure in de-novo heart transpla…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1164,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/jhlt-the-podcast-3498579/episodes/episode-76-evolocumab-s-impact-on-coronary-physiology-and-microstructure-in-de-novo-heart-transplant-recipients/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/jhlt-the-podcast-3498579/episode-76-evolocumab-s-impact-on-coronary-physiology-and-microstructure-in-de-novo-heart-transplant-recipients.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}